On 19 June 2015, orphan designation (EU/3/15/1502) was granted by the European Commission to Dr Ulrich Granzer, Germany, for trehalose for the treatment of spinocerebellar ataxia.
The sponsorship was transferred to FGK Representative Service GmbH, Germany in June 2020.
|Disease / condition||
Treatment of spinocerebellar ataxia
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.